Literature DB >> 24100977

Therapeutically reeducating macrophages to treat GBM.

Christopher Garris1, Mikael J Pittet.   

Abstract

Glioblastoma multiforme (GBM) is the most common type of aggressive malignant brain cancer. The current lack of successful therapeutics means that this disease has a dismal prognosis. However, a new study in mice offers hope for patients with GBM by demonstrating the efficacy of a novel drug that targets GBM-associated macrophages (pages 1264–1272).

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24100977     DOI： 10.1038/nm.3355

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


  14 in total

Review 1.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

2.  Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma.

Authors:  Bi Cheng Zhang; Juan Gao; Jun Wang; Zhi Guo Rao; Bao Cheng Wang; Jian Fei Gao
Journal:  Med Oncol       Date:  2010-07-30       Impact factor: 3.064

3.  Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.

Authors:  David G DeNardo; Donal J Brennan; Elton Rexhepaj; Brian Ruffell; Stephen L Shiao; Stephen F Madden; William M Gallagher; Nikhil Wadhwani; Scott D Keil; Sharfaa A Junaid; Hope S Rugo; E Shelley Hwang; Karin Jirström; Brian L West; Lisa M Coussens
Journal:  Cancer Discov       Date:  2011-06-01       Impact factor: 39.397

4.  Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

Authors:  Christian Steidl; Tang Lee; Sohrab P Shah; Pedro Farinha; Guangming Han; Tarun Nayar; Allen Delaney; Steven J Jones; Javeed Iqbal; Dennis D Weisenburger; Martin A Bast; Andreas Rosenwald; Hans-Konrad Muller-Hermelink; Lisa M Rimsza; Elias Campo; Jan Delabie; Rita M Braziel; James R Cook; Ray R Tubbs; Elaine S Jaffe; Georg Lenz; Joseph M Connors; Louis M Staudt; Wing C Chan; Randy D Gascoyne
Journal:  N Engl J Med       Date:  2010-03-11       Impact factor: 91.245

5.  Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB.

Authors:  Chiara Porta; Monica Rimoldi; Geert Raes; Lea Brys; Pietro Ghezzi; Diana Di Liberto; Francesco Dieli; Serena Ghisletti; Gioacchino Natoli; Patrick De Baetselier; Alberto Mantovani; Antonio Sica
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

Review 6.  Macrophage regulation of tumor responses to anticancer therapies.

Authors:  Michele De Palma; Claire E Lewis
Journal:  Cancer Cell       Date:  2013-03-18       Impact factor: 31.743

Review 7.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

Review 8.  Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling.

Authors:  David A Hume; Kelli P A MacDonald
Journal:  Blood       Date:  2011-12-20       Impact factor: 22.113

9.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression.

Authors:  Stephanie M Pyonteck; Leila Akkari; Alberto J Schuhmacher; Robert L Bowman; Lisa Sevenich; Daniela F Quail; Oakley C Olson; Marsha L Quick; Jason T Huse; Virginia Teijeiro; Manu Setty; Christina S Leslie; Yoko Oei; Alicia Pedraza; Jianan Zhang; Cameron W Brennan; James C Sutton; Eric C Holland; Dylan Daniel; Johanna A Joyce
Journal:  Nat Med       Date:  2013-09-22       Impact factor: 53.440

10.  "Re-educating" tumor-associated macrophages by targeting NF-kappaB.

Authors:  Thorsten Hagemann; Toby Lawrence; Iain McNeish; Kellie A Charles; Hagen Kulbe; Richard G Thompson; Stephen C Robinson; Frances R Balkwill
Journal:  J Exp Med       Date:  2008-05-19       Impact factor: 14.307
View more
  15 in total

1.  An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.

Authors:  Yunyun Liu; Xiaoyu Li; Yuanpei Zhang; Hongxuan Wang; Xiongming Rong; Jialing Peng; Lei He; Ying Peng
Journal:  Oncogene       Date:  2019-08-19       Impact factor: 9.867

2.  FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.

Authors:  Jun Yan; Ling-Yuan Kong; Jiemiao Hu; Konrad Gabrusiewicz; Denada Dibra; Xueqing Xia; Amy B Heimberger; Shulin Li
Journal:  J Natl Cancer Inst       Date:  2015-05-13       Impact factor: 13.506

3.  Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma.

Authors:  Shasha Liu; Chaoqi Zhang; Nomathamsanqa Resegofetse Maimela; Li Yang; Zhen Zhang; Yu Ping; Lan Huang; Yi Zhang
Journal:  Oncoimmunology       Date:  2019-04-17       Impact factor: 8.110

4.  Colony stimulating factor-1 receptor signaling networks inhibit mouse macrophage inflammatory responses by induction of microRNA-21.

Authors:  Cristina I Caescu; Xingyi Guo; Lydia Tesfa; Tushar D Bhagat; Amit Verma; Deyou Zheng; E Richard Stanley
Journal:  Blood       Date:  2015-01-08       Impact factor: 22.113

5.  Imaging of Tumor-Associated Macrophages in a Transgenic Mouse Model of Orthotopic Ovarian Cancer.

Authors:  Huanhuan He; Alan C Chiu; Masamitsu Kanada; Bruce T Schaar; Venkatesh Krishnan; Christopher H Contag; Oliver Dorigo
Journal:  Mol Imaging Biol       Date:  2017-10       Impact factor: 3.488

Review 6.  The biology and mathematical modelling of glioma invasion: a review.

Authors:  J C L Alfonso; K Talkenberger; M Seifert; B Klink; A Hawkins-Daarud; K R Swanson; H Hatzikirou; A Deutsch
Journal:  J R Soc Interface       Date:  2017-11       Impact factor: 4.118

7.  Regulation of the IL-10-driven macrophage phenotype under incoherent stimuli.

Authors:  Yishan Chuang; Michelle E Hung; Brianne K Cangelose; Joshua N Leonard
Journal:  Innate Immun       Date:  2016-09-26       Impact factor: 2.680

Review 8.  Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies.

Authors:  Maria B Garcia-Fabiani; Santiago Haase; Andrea Comba; Stephen Carney; Brandon McClellan; Kaushik Banerjee; Mahmoud S Alghamri; Faisal Syed; Padma Kadiyala; Felipe J Nunez; Marianela Candolfi; Antonela Asad; Nazareno Gonzalez; Marisa E Aikins; Anna Schwendeman; James J Moon; Pedro R Lowenstein; Maria G Castro
Journal:  Front Oncol       Date:  2021-06-08       Impact factor: 5.738

9.  Hypoxia induces macrophage polarization and re-education toward an M2 phenotype in U87 and U251 glioblastoma models.

Authors:  Marine M Leblond; Aurélie N Gérault; Aurélien Corroyer-Dulmont; Eric T MacKenzie; Edwige Petit; Myriam Bernaudin; Samuel Valable
Journal:  Oncoimmunology       Date:  2015-06-05       Impact factor: 8.110

10.  Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth.

Authors:  Yu Shi; Yi-Fang Ping; Wenchao Zhou; Zhi-Cheng He; Cong Chen; Bai-Shi-Jiao Bian; Lin Zhang; Lu Chen; Xun Lan; Xian-Chao Zhang; Kai Zhou; Qing Liu; Hua Long; Ti-Wei Fu; Xiao-Ning Zhang; Mian-Fu Cao; Zhi Huang; Xiaoguang Fang; Xiuxing Wang; Hua Feng; Xiao-Hong Yao; Shi-Cang Yu; You-Hong Cui; Xia Zhang; Jeremy N Rich; Shideng Bao; Xiu-Wu Bian
Journal:  Nat Commun       Date:  2017-06-01       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.